Redox Remodeling by Nutraceuticals for Prevention and Treatment of Acute and Chronic Inflammation

被引:5
|
作者
Petrarca, Claudia [1 ,2 ]
Viola, Davide [1 ]
机构
[1] Univ G dAnnunzio, Dept Med & Aging Sci, I-66100 Chieti, Italy
[2] Univ G dAnnunzio, Ctr Adv Studies & Technol, I-66100 Chieti, Italy
关键词
antioxidant; ROS; immunomodulation; nutraceuticals; probiotic; postbiotic; diabetes; ISLET AUTOIMMUNITY; IN-VITRO; BUTYRATE; CELLS; ASSOCIATION;
D O I
10.3390/antiox12010132
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antioxidant-rich dietary regimens are considered the best practice to maintain health, control inflammation, and prevent inflammatory diseases. Yet, nutraceuticals as food supplements are self-prescribed and purchasable over the counter by healthy individuals for the purpose of beneficial effects on fitness and aging. Hence, the effectiveness, safety, and correct intake of these compounds need to be better explored. Since redox-modulating activity of these compounds appears to be involved in activation and or suppression of immune cells, the preventive use of nutraceuticals is very attractive even for healthy people. This review focuses on redox- and immunomodulating nutraceuticals in the context of diabetes mellitus (DM). In fact, DM is an illustrative disease of latent and predictable inflammatory pathogenetic processes set out and sustained by oxidative stress. DM has been thoroughly investigated through in vitro and in vivo models. Furthermore, human DM is characterized by uncontrolled levels of glucose, a pivotal factor shaping immune responses. Hence, antioxidant nutraceuticals with multifaced activities, including glucose keeping, are described here. A greater number of such multi-player nutraceuticals might be identified using DM animal models and validated in clinical settings on genetic and environmental high-risk individuals.
引用
收藏
页数:22
相关论文
共 50 条
  • [11] Nutraceuticals in Acute and Prophylactic Treatment of Migraine
    Oved Daniel
    Alexander Mauskop
    Current Treatment Options in Neurology, 2016, 18
  • [12] Green tea:: prevention and treatment of cancer by nutraceuticals
    Béliveau, R
    Gingras, D
    LANCET, 2004, 364 (9439): : 1021 - 1022
  • [13] Nutraceuticals in Acute and Prophylactic Treatment of Migraine
    Daniel, Oved
    Mauskop, Alexander
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2016, 18 (04) : 1 - 8
  • [14] Nutraceuticals: Reviewing their Role in Chronic Disease Prevention and Management
    Bergamin, Amanda
    Mantzioris, Evangeline
    Cross, Giordana
    Deo, Permal
    Garg, Sanjay
    Hill, Alison M.
    PHARMACEUTICAL MEDICINE, 2019, 33 (04) : 291 - 309
  • [15] Inflammation, pain, and chronic disease: An integrative approach to treatment and prevention
    Edwards, T
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2005, 11 (06) : 20 - 27
  • [16] Remodeling and Fibrosis in Chronic Eosinophil Inflammation
    Aceves, Seema S.
    DIGESTIVE DISEASES, 2014, 32 (1-2) : 15 - 21
  • [17] Ancient Wheat as Promising Nutraceuticals for the Prevention of Chronic and Degenerative Diseases
    Basile, Giovanna
    De Maio, Azzurra Chiara
    Catalano, Alessia
    Ceramella, Jessica
    Iacopetta, Domenico
    Bonofiglio, Daniela
    Saturnino, Carmela
    Sinicropi, Maria Stefania
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (30) : 3384 - 3403
  • [18] Nutraceuticals in the Prevention and Therapeutic Treatment of Cardiovascular and Cerebrovascular Disease
    Fleenor, Bradley S.
    Carlini, Nicholas A.
    Martens, Christopher R.
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2023, 43 (03) : 162 - 169
  • [19] Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer
    Nair, Hareesh B.
    Sung, Bokyung
    Yadav, Vivek R.
    Kannappan, Ramaswamy
    Chaturvedi, Madan M.
    Aggarwal, Bharat B.
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (12) : 1833 - 1843
  • [20] Nutraceuticals - An emerging era in the treatment and prevention of cardiovascular diseases
    Ramaa, CS
    Shirode, AR
    Mundada, AS
    Kadam, VJ
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (01) : 15 - 23